Perspectives from the frontline: A pharmacy department’s response to the COVID-19 pandemic
Open Access
- 22 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 77 (17), 1409-1416
- https://doi.org/10.1093/ajhp/zxaa176
Abstract
The global coronavirus 2019 (COVID-19) pandemic has created unprecedented strains on healthcare systems around the world. Challenges surrounding an overwhelming influx of patients with COVID-19 and changes in care dynamics prompt the need for care models and processes that optimize care in this medically complex patient population. The purpose of this report is to describe our institution’s strategy to deploy pharmacy resources and standardize pharmacy processes to optimize the management of patients with COVID-19. This retrospective, descriptive report characterizes documented pharmacy interventions in the acute care of patients admitted for COVID-19 during the period April 1 to April 15, 2020. Patient monitoring, interprofessional communication, and intervention documentation by pharmacy staff was facilitated through the development of a COVID-19–specific care bundle integrated into the electronic medical record. A total of 1,572 pharmacist interventions were documented in 197 patients who received a total of 15,818 medication days of therapy during the study period. The average number of interventions per patient was 8. The most common interventions were regimen simplification (15.9%), timing and dosing adjustments (15.4%), and antimicrobial therapy and COVID-19 treatment adjustments (15.2%). Patients who were admitted to an intensive care unit care at any point during their hospital stay accounted for 66.7% of all interventions documented. A pharmacy department’s response to the COVID-19 pandemic was optimized through standardized processes. Pharmacists intervened to address a wide scope of medication-related issues, likely contributing to improved management of COVID-19 patients. Results of our analysis demonstrate the vital role pharmacists play as members of multidisciplinary teams during times of crisis.Keywords
This publication has 26 references indexed in Scilit:
- Effect of an antimicrobial stewardship bundle for patients withClostridium difficileinfectionJournal of Antimicrobial Chemotherapy, 2015
- Antimicrobial stewardship efforts to manage a pentamidine shortageAmerican Journal of Health-System Pharmacy, 2014
- Surge Capacity LogisticsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2014
- Impact of an Antimicrobial Stewardship Program Comprehensive Care Bundle on Management of CandidemiaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- A retrospective analysis of determinants of self-extubation in a tertiary care intensive care unitJournal of Emergencies, Trauma, and Shock, 2013
- Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenzaJournal of the American Pharmacists Association, 2012
- Pharmacy intervention on antimicrobial management of critically ill patientsPharmacy Practice, 2011
- Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patientsJournal of Critical Care, 2011
- ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health SystemsAmerican Journal of Health-System Pharmacy, 2009
- Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections*Critical Care Medicine, 2008